Stephen Dale Waye, LMFT | |
1097 Main St, Saint Johnsbury, VT 05819-2646 | |
(802) 304-8394 | |
Not Available |
Full Name | Stephen Dale Waye |
---|---|
Gender | Male |
Speciality | Marriage & Family Therapist |
Location | 1097 Main St, Saint Johnsbury, Vermont |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366951527 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | 100.0134068 (Vermont) | Primary |
Mailing Address | Practice Location Address |
---|---|
Stephen Dale Waye, LMFT Po Box 184, Wells River, VT 05081-0184 Ph: (802) 304-8394 | Stephen Dale Waye, LMFT 1097 Main St, Saint Johnsbury, VT 05819-2646 Ph: (802) 304-8394 |
News Archive
Scientists have mapped out the genes that keep our cells alive, creating a long-awaited foothold for understanding how our genome works and which genes are crucial in disease like cancer.
If you're considering weight loss surgery, Beverly Hills Physicians has some very special thoughts for you as we approach Independence Day 2013. Serious obesity is never easy, but it can be especially difficult during the summer. Hikes, picnics, pool parties, even out of town vacations can be a lot more difficult if you're dealing with the discomfort and health problems that go with being extremely overweight. Still, sometimes the things that make us uncomfortable also spur us into action.
EpiCept Corporation today announced that at a recent meeting with the U.S. Food and Drug Administration (FDA) the Company was provided more definitive guidance regarding the clinical development of Ceplene, the Company's lead product administered with interleukin-2 (IL-2) for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission.
Researchers from University of South Florida College of Medicine found a combination of antibiotics to be an effective treatment for Chlamydia-induced reactive arthritis, a major step forward in the management, and possibly cure, of this disease. Results of this study are published in the May issue of Arthritis & Rheumatism, a journal of the American College of Rheumatology.
› Verified 9 days ago